What Is AlloClae?
AlloClae is derived from donated human adipose tissue that undergoes a proprietary multi-step purification process. Donor fat is processed to remove all immunogenic components, including DNA, while preserving the extracellular matrix, collagen, and native growth factors.
As research published in PMC confirms, adipose tissue contains a stromal vascular fraction rich in stem cells, growth factors, and extracellular matrix components with pro-regenerative, pro-angiogenic, and tissue-remodeling properties. AlloClae harnesses those same regenerative properties, providing both immediate volume and gradual tissue integration as the body's own cells migrate into the material over the weeks that follow.
AlloClae is processed in compliance with FDA regulations for human tissue products under 21 CFR Part 1271, which governs human cells, tissues, and cellular and tissue-based products.







